Randomized, controlled trial of low-dose inhaled nitric-oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension

Pediatrics

Volumn 104, Issue 5 I, 1999, Pages 1089-1094

  Cornfield, David N ^a   Maynard, Roy C ^a,b   DeRegnier, Raye Ann O ^a,b   Guiang III, Sixto F ^a   Barbato, Joel E ^a   Milla, Carlos E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

Author keywords

Extracorporeal membrane oxygenation; Hypoxemia; Persistent pulmonary hypertension of the newborn; Pulmonary vascular reactivity; Respiratory failure

Indexed keywords

NITRIC OXIDE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESPONSE; FEMALE; GESTATIONAL AGE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; NEWBORN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; INFANT, NEWBORN; MALE; NITRIC OXIDE; OXYGEN; PARTIAL PRESSURE; PERSISTENT FETAL CIRCULATION SYNDROME; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; TREATMENT FAILURE; VASODILATOR AGENTS;

EID: 0032706502     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.104.5.1089     Document Type: Article

References (26)

1. Rudolph A. Distribution and regulation of blood flow in the fetal and neonatal lamb. Circ Res. 1985;57:811-821
2. Cassin S, Dawes GS, Mott JC, Ross BB, Strang LB. The vascular resistance of the fetal and newly ventilated lung of the lamb. J Physiol. 1964;171:61-79
3. Dawes GS, Mott JC, Widdicombe JG, Wyatt DG. Changes in the lungs of the newborn lamb. J Physiol Lond. 1953;121:141-162
4. Leffler CW, Hessler JR, Green RS. The onset of breathing at birth stimulates pulmonary vascular prostacyclin synthesis. Pediatr Res. 1984; 18:938-942
5. Christou H, Adatia I, Van Marter LJ, et al. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5′-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. J Pediatr. 1997;130:603-611
6. Kumar P, Kazzi NJ, Shankaran S. Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn. Am J Perinatol. 1996;13:335-341
7. Abman SH, Chatfield BA, Hall SL, McMurtry IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol. 1990;259:H1921-H1927
8. Cornfield D, Chatfield B, McQueston J, McMurtry I, Abman S. Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus. Am J Physiol. 1992;262:H1474-H1481
9. Stenmark K, Abman SH, Accurso FJ: Etiologic mechanisms in persistent pulmonary hypertension of the newborn. In: Reeves, JT, Weir, EK, eds. Pulmonary Vascular Physiology and Pathophysiology. New York, NY: Marcel Dekker; 1989:355-402
10. Radermacher P, Santak P, Becker H, Falke KJ: Prostaglandin E1 and nitroglycerin reduce pulmonary capillary wedge pressure but worsen V/Q distribution in patients with adult respiratory distress syndrome. Anesthesiology. 1989;70:601-609
11. Kinsella JP, Neish SR, Shaffer E, Abman SH: Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340:819-820
12. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340: 818-819
13. Roberts JJ, Fineman J, Morin FC, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med. 1997;336:605-610
14. Kinsella JP, Truog WE, Walsh WF, et al. Randomized, multicenter trial of inhaled nitric oxide in severe, persistent pulmonary hypertension of the newborn. J Pediatr. 1997;131:55-62
15. Haddad I, Ischiropoulos H, Holm B, Beckman J, Baker J, Matalon S. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol. 1993;265:L555-L564
16. Radi R, Beckman JS, Bush KM, Freeman B: Peroxynitrite-induced membrane lipid peroxidation. Arch Biochem Biophys. 1991;288:481-487
17. Hoffman GM, Ross GA, Day SE, Rice TB, Nelin LD. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med. 1997;25:352-359
18. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr. 1994;124:302-308
19. Leone AM, Gustafsson LE, Francis PL, Persson MG, Wiklund NP, Moncada S. Nitric oxide is present in exhaled breath in humans: direct GC-MS confirmation. Biochem Biophys Res Commun. 1994;201:883-887
20. Ogura H, Cioffi WG, Jordan BS. The effect of inhaled NO on smoke inhalation injury in an ovine model. J Trauma. 1994;37:294-302
21. Ogura H, Cioffi WG, Offner PJ. The effect of inhaled NO on pulmonary function following sepsis in an ovine model. Surgery. 1994;116:315-321
22. Matalon S, DeMarco V, Haddad IY, Myles C, Skimming JW, Schurch SC. Inhaled nitric oxide injures the pulmonary surfactant system of lambs in vivo. Am J Physiol. 1996;270:L273-L280
23. Oka M, Ohnishi M, Takahashi H, et al. Altered vasoreactivity in lungs isolated from rats exposed to nitric oxide gas. Am J Physiol. 1996;271: L419-L424
24. Ziegler JW, Ivy DD, Fox JJ, Kinsella JP, Clarke WR, Abman SH: Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus. Am J Physiol. 1995;269:H473-H479
25. Kinsella JP, Torielli F, Ziegler JW, Ivy DD, Abman SH. Dipyridamole augmentation of response to nitric oxide. Lancet. 1995;346:647-648. Letter
26. Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: A randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics. 1998;101:325-334